SCHOTT Pharma AG & Co. KGaA (FRA:1SXP)
14.36
-0.04 (-0.28%)
At close: Jan 30, 2026
FRA:1SXP Balance Sheet
Financials in millions EUR. Fiscal year is October - September.
Millions EUR. Fiscal year is Oct - Sep.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Cash & Equivalents | 22.47 | 23.18 | 24.36 | 28.8 | 27.86 |
Short-Term Investments | 3.2 | 3.25 | 1.53 | 1.49 | - |
Cash & Short-Term Investments | 25.67 | 26.43 | 25.89 | 30.28 | 27.86 |
Cash Growth | -2.89% | 2.09% | -14.51% | 8.71% | 49.73% |
Accounts Receivable | 281.1 | 225.45 | 223.7 | 199.05 | 150.94 |
Other Receivables | 32.41 | 33.73 | 29.71 | 28.65 | 15.76 |
Receivables | 469.49 | 401.27 | 289.69 | 390.26 | 187.13 |
Inventory | 174.98 | 146.26 | 138.94 | 128.94 | 83.52 |
Prepaid Expenses | 2.55 | 2.77 | 3.13 | 2.94 | 1.88 |
Other Current Assets | 8.72 | 7.51 | 10.69 | 2.1 | 1.77 |
Total Current Assets | 681.4 | 584.25 | 468.34 | 554.52 | 302.16 |
Property, Plant & Equipment | 785.67 | 723.49 | 637.81 | 517.21 | 334.14 |
Long-Term Investments | 88.5 | 85.06 | 79.07 | 79.83 | 62.26 |
Goodwill | 28.43 | 29.35 | 29.49 | 30.95 | 29.33 |
Other Intangible Assets | 1.26 | 1.12 | 1.45 | 1.92 | 1.72 |
Long-Term Deferred Tax Assets | 13.04 | 14.33 | 14.83 | 11.75 | 10.11 |
Other Long-Term Assets | 0.34 | 0.32 | 0.84 | 0.33 | 0.18 |
Total Assets | 1,599 | 1,438 | 1,232 | 1,197 | 739.89 |
Accounts Payable | 103.88 | 95.51 | 90.64 | 99.6 | 63.38 |
Accrued Expenses | 44.55 | 42.43 | 52.86 | 46.58 | 39 |
Short-Term Debt | 219.95 | 200.54 | 137.47 | 120.57 | 96.98 |
Current Portion of Leases | 3.81 | 4.93 | 3.14 | 3.38 | 1.39 |
Current Income Taxes Payable | 22.5 | 35.33 | 20.4 | 12.65 | 16.3 |
Current Unearned Revenue | 26.98 | 24.3 | 20.5 | 14.76 | 8.84 |
Other Current Liabilities | 32.18 | 32.45 | 26.14 | 25.49 | 18.32 |
Total Current Liabilities | 453.85 | 435.48 | 351.15 | 323.02 | 244.21 |
Long-Term Leases | 79.2 | 80.87 | 69.19 | 71.43 | 2.21 |
Long-Term Unearned Revenue | 116.7 | 78.61 | 66.14 | 39.95 | 19.85 |
Pension & Post-Retirement Benefits | 23.57 | 27.2 | 18.78 | 14.63 | 34.16 |
Long-Term Deferred Tax Liabilities | 21.99 | 19.94 | 24.82 | 20.7 | 11.75 |
Other Long-Term Liabilities | 9.58 | 7.32 | 9.57 | 17.73 | 8.3 |
Total Liabilities | 704.9 | 649.42 | 539.65 | 487.46 | 320.48 |
Common Stock | 150.62 | 150.62 | 150.62 | - | - |
Comprehensive Income & Other | 741.17 | 636.01 | 539.82 | 707.28 | 417.96 |
Total Common Equity | 891.78 | 786.63 | 690.43 | 707.28 | 417.96 |
Minority Interest | 1.97 | 1.86 | 1.75 | 1.77 | 1.46 |
Shareholders' Equity | 893.75 | 788.49 | 692.18 | 709.04 | 419.42 |
Total Liabilities & Equity | 1,599 | 1,438 | 1,232 | 1,197 | 739.89 |
Total Debt | 302.97 | 286.34 | 209.81 | 195.38 | 100.58 |
Net Cash (Debt) | -277.3 | -259.91 | -183.92 | -165.09 | -72.72 |
Net Cash Per Share | -1.84 | -1.73 | -1.22 | -1.10 | -0.48 |
Filing Date Shares Outstanding | 150.61 | 150.61 | 150.61 | 150.61 | 150.61 |
Total Common Shares Outstanding | 150.61 | 150.61 | 150.61 | 150.61 | 150.61 |
Working Capital | 227.55 | 148.77 | 117.19 | 231.5 | 57.95 |
Book Value Per Share | 5.92 | 5.22 | 4.58 | 4.70 | 2.78 |
Tangible Book Value | 862.09 | 756.16 | 659.49 | 674.41 | 386.91 |
Tangible Book Value Per Share | 5.72 | 5.02 | 4.38 | 4.48 | 2.57 |
Land | 357.5 | 336.47 | 260.95 | 240.49 | 143.56 |
Machinery | 812.35 | 730.55 | 615.67 | 565.37 | 443.39 |
Construction In Progress | 205.07 | 192.49 | 250.62 | 173.47 | 122.12 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.